New York State Common Retirement Fund »

Protalix Biotherapeutics shares owned by New York State Common Retirement Fund

Quarter-by-quarter ownership of Protalix Biotherapeutics (PLX) shares owned by New York State Common Retirement Fund from 13F filings

Historical chart of New York State Common Retirement Fund investment in Protalix Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protalix Biotherapeutics held by New York State Common Retirement Fund consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protalix Biotherapeutics by New York State Common Retirement Fund

Quarter filed Position value Share count Share price at filing
2023-12-31 $80k 45k 1.77
2023-09-30 $76k 46k 1.66
2023-06-30 $90k 45k 2.00

More positions owned by New York State Common Retirement Fund

Microsoft Corporation Common Stock (MSFT)
Apple Common Stock (AAPL)
Amazon.com Common Stock (AMZN)
Nvidia Corporation Common Stock (NVDA)
Alphabet Inc - Class A Common Stock (GOOGL)
Meta Platforms Common Stock (META)
Alphabet Inc - Class C Common Stock (GOOG)
Tesla Common Stock (TSLA)
Berkshire Hathaway Inc-cl Common Stock (BRK.B)
Unitedhealth Group Common Stock (UNH)
Eli Lilly & Company Common Stock (LLY)
Jp Morgan Chase & Company Common Stock (JPM)
Broadcom Common Stock (AVGO)
Visa Inc - Class A Common Stock (V)
Mastercard Inc Class A Common Stock (MA)

View all positions for New York State Common Retirement Fund

Top funds holding Protalix Biotherapeutics

GSA Capital Partners
Vanguard Group
Bank of America Corporation
Bank of New York Mellon
Charles Schwab Investment Management
Barclays
Goldman Sachs Group
Citadel Advisors
Orin Green Financial
UBS Group
OZ Management
Rhumbline Advisers
Connor, Clark & Lunn Investment Management
Bailard
Commonwealth Equity Services

View all funds holding Protalix Biotherapeutics